TMPRSS2:ERG Fusion Gene and Androgen Ablation Therapy in Prostate Cancer Reply

被引：0
|
作者：
Al-Ahmadie, Hikmat A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2010年 / 134卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：965 / 965
页数：1
相关论文
共 50 条
  • [41] Molecular Pathways Altered in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancers
    Chatterjee, D.
    Ayala, G.
    Iiimann, M.
    LABORATORY INVESTIGATION, 2014, 94 : 220A - 220A
  • [42] Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review
    Sanguedolce, Francesca
    Cormio, Antonella
    Brunelli, Matteo
    D'Amuri, Alessandro
    Carrieri, Giuseppe
    Bufo, Pantaleo
    Cormio, Luigi
    CLINICAL GENITOURINARY CANCER, 2016, 14 (02) : 117 - 121
  • [43] TMPRSS2:ERG fusion enhances osteoblastic phenotype of prostate cancer bone metastases
    Delliaux, Carine
    Tian, V. Tian
    Bouchet, Mathilde
    Fradet, Anais
    Vanpouille, Nathalie
    Flourens, Anne
    Deplus, Rachel
    Leroy, Xavier
    de Launoit, Yvan
    Bonnelye, Edith
    Duterque-Coquillaud, Martine
    CANCER RESEARCH, 2016, 76
  • [44] Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
    G Attard
    J Clark
    L Ambroisine
    G Fisher
    G Kovacs
    P Flohr
    D Berney
    C S Foster
    A Fletcher
    W L Gerald
    H Moller
    V Reuter
    J S De Bono
    P Scardino
    J Cuzick
    C S Cooper
    Oncogene, 2008, 27 : 253 - 263
  • [45] Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors
    Mcgrath, Colleen B.
    Shreves, Alaina H.
    Shanahan, Megan R.
    Guard, Hannah E.
    Nhliziyo, Manelisi V.
    Pernar, Claire H.
    Penney, Kathryn L.
    Lotan, Tamara L.
    Fiorentino, Michelangelo
    Mucci, Lorelei A.
    Stopsack, Konrad H.
    INTERNATIONAL JOURNAL OF CANCER, 2024,
  • [46] Noninvasive detection of TMPRSS2: Erg fusion transcripts in the urine of men with prostate cancer
    Morris, David S.
    Tomlins, Scott A.
    Laxman, Bharathi
    Mehra, Rohit
    Shah, Rajal B.
    Rubin, Mark A.
    Wei, John T.
    Chinnaiyan, Arul M.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 565 - 566
  • [47] Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
    Attard, G.
    Clark, J.
    Ambroisine, L.
    Fisher, G.
    Kovacs, G.
    Flohr, P.
    Berney, D.
    Foster, C. S.
    Fletcher, A.
    Gerald, W. L.
    Moller, H.
    Reuter, V.
    De Bono, J. S.
    Scardino, P.
    Cuzick, J.
    Cooper, C. S.
    ONCOGENE, 2008, 27 (03) : 253 - 263
  • [48] Association of common genetic variants with TMPRSS2 ERG fusion status in prostate cancer
    Kohaar, Indu
    Ravindranath, Lakshmi
    Young, Denise
    Ali, Amina
    Li, Qiyuan
    Dobi, Albert
    McLeod, David
    Rosner, Inger L.
    Sesterhenn, Isabell
    Freedman, Matthew
    Srivastava, Shiv
    Petrovics, Gyorgy
    CANCER RESEARCH, 2017, 77
  • [49] Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
    Laxman, Bharathi
    Tomlins, Scott A.
    Mehra, Rohit
    Morris, David S.
    Wang, Lei
    Helgeson, Beth E.
    Shah, Rajal B.
    Rubin, Mark A.
    Wei, John T.
    Chinnaiyan, Arul M.
    NEOPLASIA, 2006, 8 (10): : 885 - 888
  • [50] Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors
    McGrath, Colleen B.
    Shreves, Alaina H.
    Shanahan, Megan R.
    Guard, Hannah E.
    Nhliziyo, Manelisi V.
    Penney, Kathryn L.
    Lotan, Tamara L.
    Fiorentino, Michelangelo
    Stopsack, Konrad H.
    Mucci, Lorelei A.
    CANCER RESEARCH, 2024, 84 (06)
12345